Metastatic chordoma with pancreatic disease and response to imatinib

Eleanor V. Klejnow*, Katie Hoban, Ioanna Nixon, Thomas Robert Elswood

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Downloads (Pure)

Abstract

A 45-year-old woman presented with a left-sided neck swelling following treatment a year prior for cervical spine chordoma. She had initially been managed surgically with a cervical vertebrectomy and a course of proton beam therapy. Although there had been a degree of residual tissue, her disease remained stable radiologically and clinically. Repeat MRI demonstrated an increasing left paravertebral mass and a head of pancreas metastasis, which shared pathological characteristics with chordoma. Given the advanced metastatic nature of her disease, imatinib was offered with a palliative intent. While waiting for treatment she developed a spinal cord compression, managed with radiotherapy. She commenced imatinib and her disease remained stable for 9 months before progressing clinically and radiologically. This case demonstrates an unusual pattern of metastatic chordoma and provides further rationale for imatinib in such patients.

Original languageEnglish
Article numbere240062
JournalBMJ Case Reports
Volume15
Issue number1
Early online date19 Jan 2022
DOIs
Publication statusPublished - 19 Jan 2022

Keywords

  • cancer intervention
  • malignant disease and immunosuppression
  • oncology
  • pharmacology and therapeutics
  • tyrosine kinase inhibitor

Fingerprint

Dive into the research topics of 'Metastatic chordoma with pancreatic disease and response to imatinib'. Together they form a unique fingerprint.

Cite this